share_log

Telehealth Market News: Braxia Scientific Enters Industry By Acquiring Ketamine Treatment Platform In Florida

Telehealth Market News: Braxia Scientific Enters Industry By Acquiring Ketamine Treatment Platform In Florida

遠程健康市場消息:布拉夏科學通過收購佛羅裏達州的氯胺酮治療平臺進入行業
Benzinga Real-time News ·  2022/08/03 14:54
A researcher and provider of ketamine-assisted treatments for mental health conditions, Braxia Scientific Corp. (OTC:BRAXF) has completed the acquisition of the issued and outstanding stock of U.S.-based, private telemedicine company KetaMD Inc., with the goal of addressing mental health issues by providing access to technology-mediated ketamine treatments.
一名研究人員和精神健康疾病氯胺酮輔助治療的提供者,布拉夏科學公司(場外交易代碼:BRAXF)已完成收購已發行及已發行的總部位於美國的私人遠程醫療公司KetaMD Inc.,目的是通過提供獲得技術介導氯胺酮治療的機會來解決精神健康問題。
Founded by psychedelic pioneers Zappy Zapolin and Warren Gumpel along with mindfulness instructor Kaia Roman and president and COO Leann Taylor, KetaMD's telemedicine platform works to provide access to safe and affordable at-home ketamine treatments for those suffering from depression and related mental health conditions across...
由迷幻先驅創立扎皮·扎波林和沃倫·古佩爾與正念導師一起卡亞·羅曼總裁和首席運營官莉安·泰勒Ket...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論